DIADEM US

was founded in 2012 as a spin-off of University of Brescia (Italy). Diadem is a pure diagnostic company committed to carry on specific research and development on early peripheral markers of Alzheimer's disease into technology, bringing together some of the most senior experts from industry and academia to advance a breakthrough in Alzheimer's disease in the clinic... Diadem is a pure diagnostic company committed to carry on specific research and development on early peripheral markers of Alzheimer's disease into technology, bringing together some of the most senior experts from industry and academia to advance a breakthrough in Alzheimer's disease in the clinic. Diadem is preparing for large retrospective and prospective trials to confirm initial data... Diadem is determined to solve one of the biggest problems in Alzheimer's disease drug development and patient care: early, accurate, predictive, fast, non-invasive and cost effective diagnosis.

Also known as: Diadem, Diadem US, Inc

Primary location: Milano Italy